1. Home
  2. APWC vs PLRX Comparison

APWC vs PLRX Comparison

Compare APWC & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

APWC

Asia Pacific Wire & Cable Corporation Ltd. (Bermuda)

HOLD

Current Price

$1.50

Market Cap

61.4M

Sector

Industrials

ML Signal

HOLD

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.07

Market Cap

65.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APWC
PLRX
Founded
1996
2015
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.4M
65.6M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
APWC
PLRX
Price
$1.50
$1.07
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$2.67
AVG Volume (30 Days)
12.1K
407.4K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.97
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$1.02
52 Week High
$2.34
$1.95

Technical Indicators

Market Signals
Indicator
APWC
PLRX
Relative Strength Index (RSI) 44.64 47.40
Support Level $1.30 N/A
Resistance Level $1.63 $1.27
Average True Range (ATR) 0.09 0.03
MACD -0.00 0.01
Stochastic Oscillator 36.65 62.50

Price Performance

Historical Comparison
APWC
PLRX

About APWC Asia Pacific Wire & Cable Corporation Ltd. (Bermuda)

Asia Pacific Wire & Cable Corp Ltd is a holding company. It is principally engaged in the manufacture and distribution of enameled wire, power cable, and telecommunications products in Thailand, Singapore, Australia, the PRC, Hong Kong, and certain other markets in the Asia Pacific region. It also provides project engineering services in the supply, delivery, and installation of power cables (SDI). Some of the company's products are Bare wires, Power cables, Communication cables, Electronic wires & cables, and Enamelled wires. The company's geographical segments are North Asia, Thailand, and the rest of the World.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: